These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 27760335)
1. Two Bugs a NOD Away from Improving Cancer Therapy Efficacy. Araya RE; Goldszmid RS Immunity; 2016 Oct; 45(4):714-716. PubMed ID: 27760335 [TBL] [Abstract][Full Text] [Related]
2. [Gut microbiota and efficacy of cancer therapies]. Vétizou M; Daillère R; Zitvogel L Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731 [TBL] [Abstract][Full Text] [Related]
4. Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling. Ohlsson C; Nigro G; Boneca IG; Bäckhed F; Sansonetti P; Sjögren K Cell Immunol; 2017 Jul; 317():55-58. PubMed ID: 28576260 [TBL] [Abstract][Full Text] [Related]
5. The Hidden Effect of Nod2 in the Host/Microbiota Relationship. Daniel N; Chassaing B Cell Mol Gastroenterol Hepatol; 2020; 10(2):424-425. PubMed ID: 32479755 [No Abstract] [Full Text] [Related]
6. Nod2 Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect. Al Nabhani Z; Lepage P; Mauny P; Montcuquet N; Roy M; Le Roux K; Dussaillant M; Berrebi D; Hugot JP; Barreau F J Crohns Colitis; 2016 Dec; 10(12):1428-1436. PubMed ID: 27147452 [TBL] [Abstract][Full Text] [Related]
7. Microbiota: a key orchestrator of cancer therapy. Roy S; Trinchieri G Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904 [TBL] [Abstract][Full Text] [Related]
17. Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria. Ji G; Zhao J; Si X; Song W Adv Drug Deliv Rev; 2024 Aug; 211():115345. PubMed ID: 38834140 [TBL] [Abstract][Full Text] [Related]
18. Human microbiota and effectiveness of cancer chemotherapy. Shvets YV; Lukianova NY; Chekhun VF Exp Oncol; 2020 Jun; 42(2):82-93. PubMed ID: 32602287 [TBL] [Abstract][Full Text] [Related]
19. Emerging pathogenic links between microbiota and the gut-lung axis. Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885 [TBL] [Abstract][Full Text] [Related]
20. The microbiome and innate immunity. Thaiss CA; Zmora N; Levy M; Elinav E Nature; 2016 Jul; 535(7610):65-74. PubMed ID: 27383981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]